Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5811 posts found.

Vasopharm GmbH announces positive data from clinical trials in traumatic brain injury

July 12, 2022 Manufacturing and Production

Vasopharm GmbH has announced the results of significantly reduced brain microdialyse lactate levels in the Phase II (NOSTRA) and Phase …
News

Application to FDA for first-ever over-the-counter birth control pill

July 12, 2022 Manufacturing and Production

The FDA is due to consider whether oral birth control medication should be made available to consumers over the counter, …
News

Hospitals around UK reintroduce mandatory face masks amid COVID surge

July 5, 2022 Manufacturing and Production

Patients, visitors and staff are once again being told to wear face masks in hospitals across the UK, due to …
News

Mogrify and Astellas collaborate for research on treatments for sensorineural hearing loss

July 5, 2022 Manufacturing and Production

Mogrify and Astellas have announced a collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing …
News

New test aims to tackle prostate cancer rates in Black men

July 5, 2022 Manufacturing and Production

A new genetic blood test is being developed for Black men, using DNA information and AI technology, aiming to combat …
News

UK doctors warn of industrial action, call for pay rise

June 28, 2022 Manufacturing and Production

Members of the British Medical Association (BMA) have voted to press ministers to agree to a pay rise of up …
News

BASILEA announces positive results of Phase IIII study into SAB treatment

June 28, 2022 Manufacturing and Production

Basilea Pharmaceutica has announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult …
News

EMA grants Bavarian Nordic’s respiratory treatment access to priority medicines scheme

June 28, 2022 Manufacturing and Production

The EMA has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in the active immunisation for the …
News

Positive CHMP opinion for biosimilar for cancer treatment

June 28, 2022 Manufacturing and Production

The CHMP of the EMA has adopted a positive opinion for the marketing authorisation of a bevacizumab biosimilar candidate, Vegzelma. …
News

First patient enrolled in melanoma study

May 24, 2022 Manufacturing and Production

Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) have announced the screening of the first …
News

35 common health conditions GPs will no longer issue a prescription for

May 24, 2022 Manufacturing and Production

The NHS has published a list of 35 conditions that no longer require a prescription from a GP. These include …
News

131 confirmed cases of monkeypox reported in 19 countries

May 24, 2022 Manufacturing and Production

UK officials have warned that monkeypox could turn into a Europe-wide endemic if pets catch the virus. This could also …
News

Regeneron treatment fights ultra-rare form of high cholesterol in children

May 24, 2022 Manufacturing and Production

Regeneron has shared positive results from its Phase III trial of a candidate drug, for children with a rare, life-threatening …
News

Study launched to investigate COVID-19 vaccine in young immunocompromised

May 17, 2022 Manufacturing and Production

The UK’s largest kidney research charity has announced the launch of a study into the protection offered by COVID-19 vaccines …
News

WHO delivers 20 ambulances to Ukraine

May 10, 2022 Manufacturing and Production

In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …
News

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024